Designing Antibacterial Nanomaterials Under Evolutionary Constraint

Wafaa Farouk Mohamed^1,

¹Microbiology Department. Ain Shams University Specialized Hospital, Cairo, Egypt

Cite this paper:
Wafaa Farouk Mohamed. Designing Antibacterial Nanomaterials Under Evolutionary Constraint. Journal of Applied & Environmental Microbiology. 2026; 14(1):14-23. doi: 10.12691/jaem-14-1-3

Abstract

The rapid expansion of antibacterial nanomaterials has been driven by the assumption that nanoscale antimicrobials are intrinsically resistant to bacterial adaptation, reinforcing a kill-centric view of antimicrobial efficacy. Accumulating evidence now demonstrates that sublethal and chronic exposure to antibacterial nanomaterials under clinically and environmentally relevant conditions can promote bacterial tolerance, persistence, and adaptive survival. In this Review, we synthesize experimental and conceptual studies showing that conventional evaluation frameworks, particularly minimum inhibitory concentration–based metrics, repeatedly fail to capture these adaptive responses. An argument about antibacterial nanomaterials should be reconceptualized as evolutionary interventions whose long-term performance is governed by the selective pressure landscapes they generate. We outline an adaptation-aware design framework linking nanomaterial properties to exposure dynamics and predictable evolutionary outcomes, and discuss how temporal control, multimodal strategies, and biofilm-informed design can mitigate maladaptive trajectories. Recognizing bacterial adaptation as the rule rather than the exception is essential for developing sustainable nano-enabled antimicrobial strategies. Here, we argue that antibacterial nanomaterials should be understood and evaluated primarily as evolutionary pressure–shaping interventions rather than as resistance-proof bactericidal agents.

Keywords:
Antibacterial nanomaterials Selective pressure Bacterial tolerance Adaptive evolution Evolution-aware design

This work is licensed under a Creative Commons Attribution 4.0 International License. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/

References:

[1]	Huh, A. J. & Kwon, Y. J. (2011). Nanoantibiotics: A new paradigm for infectious disease treatment. Journal of Controlled Release 156, 128–145.
[2]	Gupta, A. et al. (2019). Combatting antibiotic-resistant bacteria using nanomaterials. Chemical Society Reviews 48, 415–427.
[3]	Kamat, S. & Kumari, M. (2023). Emergence of microbial resistance against nanoparticles: Mechanisms and strategies. Frontiers in Microbiology 14, 1102615.
[4]	Harada, K. & Asai, T. (2010). Selective pressure and antimicrobial resistance prevalence. Journal of Biomedicine and Biotechnology 2010, 180682.
[5]	Maeda, T. & Furusawa, C. (2024). Laboratory evolution of antimicrobial resistance in bacteria to develop rational treatment strategies. Antibiotics 13, 94.
[6]	Souque, C., González Ojeda, I. & Baym, M. (2024). Evolutionary mechanisms driving antimicrobial resistance. Annual Review of Microbiology 78, 361–382.
[7]	Duval, R. E., Gouyau, J. & Lamouroux, E. (2019). Limitations of recent studies dealing with the antibacterial properties of silver nanoparticles: Fact and opinion. Nanomaterials 9, 1775.
[8]	Wang, L., Hu, C. & Shao, L. (2017). Antimicrobial activity of nanoparticles. International Journal of Nanomedicine 12, 1227–1249.
[9]	McNeilly, O. et al. (2021). Emerging concern for silver nanoparticle resistance. Frontiers in Microbiology 12, 652863.
[10]	Modi, S. K. et al. (2023). Mechanistic insights into nanoparticle surface–bacterial membrane interactions in overcoming antibiotic resistance. Frontiers in Microbiology 14, 1135579.
[11]	Ikuma, K., Decho, A. W. & Lau, B. L. T. (2015). Nanoparticle–biofilm interactions governing environmental fate. Frontiers in Microbiology 6, 591.
[12]	Sindeldecker, D. & Stoodley, P. (2021). Antibiotic resistance and tolerance strategies. Biofilm 3, 100056.
[13]	Mohanta, Y. K. et al. (2023). Nanotechnology in combating biofilm: A smart and promising therapeutic strategy. Frontiers in Microbiology 13, 1028086.
[14]	Alfei, S. et al. (2024). ROS-mediated antibacterial oxidative therapies: Mechanisms and emerging strategies. International Journal of Molecular Sciences 25, 7182.
[15]	Krzepiłko, A. et al. (2023). Sublethal zinc oxide nanoparticle exposure induces bacterial adaptation. Pathogens 12, 485.
[16]	Zhang, P. et al. (2022). Nanoparticles promote bacterial antibiotic tolerance via osmotic stress. Small 18, 2105525.
[17]	Alabresma, A. et al. (2020). Nanoparticles as antibiotic-delivery vehicles overcome multidrug resistance: The grenade hypothesis. Journal of Global Antimicrobial Resistance 22, 811–817.
[18]	Baptista, P. V. et al. (2018). Nano-strategies to fight multidrug-resistant bacteria. Frontiers in Microbiology 9, 1441.
[19]	Brauner, A., Fridman, O., Gefen, O. & Balaban, N. Q. (2016). Distinguishing resistance, tolerance and persistence to antimicrobial treatment. Nature Reviews Microbiology 14, 320–330.
[20]	Sulaiman, J. E. & Lam, H. (2021). Evolution of bacterial tolerance under antimicrobial pressure. Frontiers in Microbiology 12, 617412.
[21]	Mouzakis, A. et al. (2025). A comprehensive review of nanoparticles in the fight against antimicrobial resistance. Pathogens 14, 1090.
[22]	Graves, J. L. et al. (2015). Rapid evolution of silver nanoparticle resistance in Escherichia coli. Frontiers in Genetics 6, 42.
[23]	Ammendolia, M. G. & De Berardis, B. (2022). Nanoparticle-driven bacterial adaptation: Focus on nano-titania. Nanomaterials 12, 3616.
[24]	Truu, M. et al. (2022). Impact of silver nanoparticles on biofilm communities and resistance genes. Journal of Hazardous Materials 440, 129721.
[25]	Ciofu, O. & Tolker-Nielsen, T. (2019). Tolerance and resistance of Pseudomonas aeruginosa biofilms to antimicrobial agents. Frontiers in Microbiology 10, 913.
[26]	Ngoepe, M. P., Schoeman, S. & Roux, S. (2025). Challenges associated with the use of metal and metal oxide nanoparticles as antimicrobial agents: Resistance mechanisms and environmental implications. Biotechnology Journal 20, e70066.
[27]	Hochvaldová, L. et al. (2022). Antibacterial nanomaterials as tools against antimicrobial resistance. Nanotechnology Reviews 11, 1115–1142.
[28]	Wen, X. et al. (2016). Limitations of MIC as a sole metric of antimicrobial response. Scientific Reports 6, 37907.
[29]	Magréault, S. et al. (2022). When and how to use MIC in clinical practice. Antibiotics 11, 1748.
[30]	Lynch, I., Salvati, A. & Dawson, K. A. (2009). Protein corona formation at the bio–nano interface. Nature Nanotechnology 4, 546–547.
[31]	Fadeel, B. et al. (2018). Advanced tools for the safety assessment of nanomaterials. Nature Nanotechnology 13, 537–543.
[32]	Lekamge, S. et al. (2018). Ecotoxicological impacts of silver nanoparticles. Frontiers in Environmental Science 6, 152.
[33]	Pachghare, P. et al. (2025). Combating multidrug resistance with silver nanoparticles: A systematic review. The Microbe 9, 100608.
[34]	Iaconis, A. et al. (2024). Anti-biofilm strategies: A focused review on innovative approaches. Microorganisms 12, 639.
[35]	Afrasiabi, S. & Partoazar, A. (2024). Targeting bacterial biofilm-related genes using nanoparticle-based strategies. Frontiers in Microbiology 15, 1387114.
[36]	Abdelhamied, N., Abdelrahman, F., El-Shibiny, A. & Hassan, R. Y. A. (2023). Bacteriophage-based nano-biosensors for fast impedimetric pathogen detection in food samples. Scientific Reports 13, 3498.
[37]	Xia, Q. et al. (2024). Advances in engineered nano-biosensors for bacteria diagnosis and multidrug-resistance inhibition. Biosensors 14, 59.